Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
Sponsor: Sanofi
Lung Transplant Rejection
United States, Australia, Austria, Belgium, Canada +14 more
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 1
Japan
Sponsor: AstraZeneca
B-cell Non-Hodgkin Lymphoma
United States, Australia, China, Italy, Japan +3 more
- A Phase 1 Study of Acalabrutinib in Japanese Adult Patients With Advanced B-cell MalignanciesCompleted
Sponsor: AstraZeneca
Part1: Advanced B-cell Malignancies · Part2: r/rCLL and r/rMCL · Part3: Untreated CLL
Japan
Sponsor: Haihe Biopharma Co., Ltd.
PIK3CA-Related Overgrowth Spectrum (PROS) · PIK3CA-related Vascular Malformations (PRVM)
China, Japan
- A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)Active Not Recruiting
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Desmoid Tumor · Aggressive Fibromatosis
Japan
Sponsor: AstraZeneca
Heart Failure and Impaired Kidney Function
United States, Argentina, Australia, Austria, Brazil +34 more
Sponsor: Pfizer
Colitis, Ulcerative
Canada, France, Germany, Israel, Italy +3 more
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseaseRecruiting
Sponsor: Novartis Pharmaceuticals
Alzheimer's Disease
United States, Australia, Canada, China, Czechia +10 more
- A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.Active Not Recruiting
Sponsor: AstraZeneca
Chronic Kidney Disease and Hypertension
United States, Argentina, Australia, Belgium, Brazil +33 more
Sponsor: Cosomil, Inc.
Pancreatic Cancer · Pancreatic Neoplasms
Japan
Sponsor: Merck Sharp & Dohme LLC
Lung Neoplasms · Non-Small-Cell Lung Carcinoma
United States, Brazil, Canada, Chile, China +18 more
- Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia GravisRecruiting
Sponsor: Novartis Pharmaceuticals
Generalized Myasthenia Gravis
United States, France, Japan, United Kingdom
Sponsor: Taiho Oncology, Inc.
NSCLC, Stage IB-IIIA · Lung Cancer · Adjuvant · Post-surgical
United States, Argentina, Australia, Belgium, Brazil +19 more
- TEZSPIRE (Tezepelumab) Asthma Japan Post-Marketing Study (PMS)Active Not Recruiting
Sponsor: AstraZeneca
Bronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)
Japan
Sponsor: Taiho Oncology, Inc.
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations
United States, Australia, Canada, France, Germany +7 more
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)Completed
Sponsor: Novo Nordisk A/S
Early Alzheimer´s Disease
United States, Argentina, Australia, Austria, Belgium +33 more
Sponsor: Bayer
MTAP-deleted Solid Tumors
United States, Australia, Belgium, China, Czechia +8 more
Sponsor: Kowa Research Institute, Inc.
NASH
United States, Argentina, Brazil, Canada, Japan +1 more
Sponsor: Amgen
Atopic Dermatitis
United States, Australia, Belgium, Brazil, Canada +16 more
Sponsor: AbbVie
Moderate to Severe Glabellar Lines
Japan
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Brazil, Chile +20 more
Sponsor: AbbVie
Glabellar Lines
China, Japan, Taiwan
Sponsor: Kowa Research Institute, Inc.
Primary Biliary Cholangitis
United States, Canada, Japan
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Austria, Brazil, Bulgaria, Canada +10 more